Telemus Capital’s AstraZeneca AZN Stock Holding History

Telemus Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$642K	Buy	4,767 +290	+6%	+$37.7K	0.05%	208
2023 Q3	$606K	Buy	4,477 +521	+13%	+$71.2K	0.06%	197
2023 Q2	$566K	Buy	3,956 +1,029	+35%	+$151K	0.05%	212
2023 Q1	$406K	Sell	2,927 -84	-3%	-$11.3K	0.04%	238
2022 Q4	$426K	Buy	3,011 +40	+1%	+$5.02K	0.04%	238
2022 Q3	$326K	Buy	+2,971	New	+$377K	0.03%	242
2016 Q4	–	Sell	-4,347	Closed	-$286K	–	307
2016 Q3	$286K	Sell	4,347 -1,946	-31%	-$127K	0.03%	282
2016 Q2	$380K	Sell	6,293 -111	-2%	-$6.45K	0.05%	243
2016 Q1	$361K	Buy	+6,404	New	+$385K	0.06%	229

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return